FDA Oversight of Nanotechnology Applications in Foods, Food Packaging, and Nutrient Delivery

Similar documents
Food Additives Program

The Path to U.S. Market for Functional Food Ingredients

Overview of Regulatory Science of Food Contact Substances

May 7, Dear Mr. Landa:

2014 FDA/JIFSAN Food & Nutrition Webinar

FDA s Food Additives Program

Safety Evaluation for Substances Directly Added to Food

Purpose of this Document

December 4, 2017 VIA ELECTRONIC SUBMISSION

GRAS Overview and Industry Perspectives. Janet Balson International Food Additives Council

memorandum Venable s FDA Practice Group FDA Publishes Draft Guidance on New Dietary Ingredients ( NDIs )

FDA Regulation of Diagnostic Tests Jeffrey N. Gibbs Hyman, Phelps & McNamara, P.C. Washington, DC

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Genetically Modified Organism (GMO) Legislation and Litigation: Challenges and Opportunities

Premarket Review. FFDCA Section 201(s) FFDCA Section 201(s) (cont.)

GROCERY MANUFACTURERS ASSOCIATION. Science Forum. Connecting Sound Science and Responsible Solutions

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015

The Basics of the U.S. FDA s Regulation of Materials Used in Food Packaging Applications

Getting Your Ingredient to Market: Understanding Your Regulatory Options Venable LLP

Listing of Color Additives Exempt from Certification; Synthetic Iron Oxide

TOBACCO PRODUCT OR MEDICAL PRODUCT?

July 3, Re: Proposed Rule: National Bioengineered Food Disclosure Standard. 83 FR (May 4, 2018). Docket No. AMS-TM

Update FDA/Center for Food Safety and Applied Nutrition

Migration and Exposure Considerations Jessica Cooper, PhD

Characterization of commercially available nanosilver-polymer composite food packaging

Agency Information Collection Activities; Submission for Office of Management and Budget

Global Regulation of Food Additives

US Whole Grain Regulatory & Policy Framework

ACTION: Notification; declaratory order; extension of compliance date.

FSMA, FSVP, and FCS. Deborah Attwood May 12, 2016 Global Food Contact 2016

Client Alert. FDA Draft Guidance Broadens New Dietary Ingredient Definition and Extends Notification Requirements 1

Agency Information Collection Activities; Submission for Office of Management and

Inter-Agency Overlap and Jurisdictional Boundaries

NDI: LOOKING BACK & AHEAD

Agenda. What we do. GMA - Overview 30,000. Public Private Partnerships in the Development of Food Safety Regulations. $415 billion

Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program

Medical Devices and the Public s Health: The FDA 510(k) Clearance Process at 35 Years. Written Statement of

Laura Beatriz Herrero Montarelo, Maria Dolores Gómez Vázquez and Victorio José Teruel Muñoz

September 28, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

Primer: Medical Device User Fee Amendments Han Zhong l September 2011

Advancing Use of Patient Preference Information as Scientific Evidence in Medical Product Evaluation Day 2

Draft Guidance for Industry and FDA Staff

Module 34: Legal aspects, ADI and GRAS status of food additives

Introduction. Current status of 510(k) clinical data requirements. 1 Current Status&Considerations:

FDA Regulation of Claims on Dietary Supplement and Food Products

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018

Incorporating Computational Approaches into Safety Assessment

LIVE INTERACTIVE YOUR DESKTOP. Food Recall Process. Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement

CFSAN Update Michael M. Landa

RECOMMENDATIONS FOR ADVERSE EVENT MONITORING PROGRAMS FOR DIETARY SUPPLEMENTS: EXECUTIVE SUMMARY

George Misko is a Partner at Keller and Heckman LLP George joined Keller and Heckman in Mr. Misko's practice focuses on food and drug matters

June 9, U.S. Food and Drug Administration Division of Dockets Management, HFA Fishers Lane, Room 1061 Rockville, MD 20852

FDA issues final guidance on benefit-risk factors to consider in medical device product availability, compliance, and enforcement decisions

Philip Morris USA Inc. v. FDA

Center for Food Safety & Applied Nutrition: Update

Pesticide Inert Ingredient Activities

Fruit Juice and Vegetable Juice as Color Additives in Food: Guidance for Industry

The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years

Nutritional Criteria for Labeling Claims

Harnessing chemical and toxicological data for the evaluation of food ingredients and packaging

FDA 510(k) 101 The Basics

REGULATIONS IN FOOD INGREDIENTS

U.S. FDA Perspective on Food Supplements/TM

Status Update on the Review of DMFs

GRAS Overview and Industry Perspectives. Priscilla Zawislak Ashland, Inc. International Food Additives Council

Changing practice to support service delivery

Food Irradiation: FDA s Perspective Teresa Croce, Ph.D.

Session 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients

Navigating the Regulatory Environment for Food Contact Applications in the USA. PMA 2014 Annual Meeting

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA

Compare Results. 153 Replacements 26 Insertions 344 Deletions. Total Changes. Styling and. Content. 0 Annotations. Old File: New File:

Medical Device Regulatory Decision Points

The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j))

RE: CONSULTATION ON DRAFT - DRUG AND NATURAL HEALTH PRODUCTS RECALL GUIDE

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9

BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE. Yuan Xu 18- JAN- 2018

Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044

Overview Consumer Health Products Law and Compliance Issues

NATURAL RESOURCES DEFENSE COUNCIL

Review of Controlled Drugs and Substances Act

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893

HISTORY, CAPACITY AND POSITION

Regulation of Dietary Supplements

EHR Developer Code of Conduct Frequently Asked Questions

STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES

Tobacco Product Applications: FDA Perspective

Gyan Rai, PhD 06/04/2015

SAFETY ASSESSMENT OF FOOD ADDITIVES

Overhauling The 510(k) Process

Guideline on the Regulation of Therapeutic Products in New Zealand

Chemical food safety in the U.S. analysis of FDA s scientific basis for assessing chemical risk. Tom Neltner October 9, 2014

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association

Over the Counter Hearing Aids:

Using new scientific knowledge to update regulations in the U.S.

OTC Drug Monograph Reform FDLI Annual Conference May 4, 2018

Agency Information Collection Activities; Submission for Office of Management and

Withdrawal of Proposed Rule on Supplemental Applications Proposing Labeling Changes for

Transcription:

FDA Oversight of Nanotechnology Applications in Foods, Food Packaging, and Nutrient Delivery Laura M. Tarantino, Ph.D. Office of Food Additive Safety Center for Food Safety and Applied Nutrition (CFSAN) US FOOD AND DRUG ADMINISTRATION The National Academies Keck Center Washington, DC December 10, 2008

FDA NANOTECHNOLOGY TASK FORCE REPORT JULY 25, 2007 http://www.fda.gov/nanotechnology/ taskforce/report2007.html

Nanotechnology Report Includes A synopsis of the state of the science for biological interactions of nanoscale materials Analysis and recommendations for science issues; and Analysis and recommendations for regulatory policy issues.

Nanotechnology Report Regulatory Issues Can FDA identify products containing nanoscale materials? What is the scope of FDA s authorities to evaluate the safety and effectiveness of such products? The scope of FDA s authorities depends on whether a product is subject to premarket authorization or not

Dietary Ingredients in Dietary Supplements Colors added to food Food Additives and Ingredients Direct food additives Food additives that are food contact substances Food ingredients whose use is Generally Recognized as Safe

Food Drug & Cosmetic Act 1958 Amendment to the Act Defines food additive Establishes the standard of safety Requires premarket approval of new uses of food additives Provides for a GRAS exemption 1960 Amendment to the Act Defines color additive Requires premarket approval of new uses of color additives

Scope of FDA Regulatory Authority Pertaining to Food Additives that are Food Contact Substances Require approval before marketing Results in an effective notification Approval is restricted to notifier

Scope of FDA Regulatory Authority Pertaining to Food and Color Additives Require approval before marketing Result in a regulation prescribing the conditions under which the additive may be safely used Regulations are generic that is, they are not licenses and approvals cover all manufacturers

Scope of FDA Regulatory Authority Pertaining to Food Ingredients Whose Use is Generally Recognized as Safe (GRAS) Do not require approval before marketing Safety must be generally recognized by qualified experts Voluntary notification

Scope of FDA Regulatory Authority Pertaining to Dietary Supplements Dietary ingredients in dietary supplements are exempt from the definition of food additive Do not require approval before marketing New dietary ingredients subject to required notification

Dietary Ingredients in Dietary Supplements Colors added to food Food Additives and Ingredients Direct food additives Food additives that are food contact substances Food ingredients whose use is Generally Recognized as Safe

Nanotechnology and Regulatory Status Questions to consider Has changing the size affected the safety? Is it the same substance? Industry is responsible for ensuring that any necessary data are developed and that premarket approval is obtained if required for nanosized ingredients

Nanotechnology and Regulatory Status The use of a substance in the nano form may or may not be GRAS even if the use of a substance in the macro form is GRAS Information underpinning safety must be Generally available Generally recognized Must relate to the substance under consideration

Nanotechnology: The Path Forward Case studies: In collaboration with the Woodrow Wilson Institute to consider potential issues related to nanotechnology and active packaging Public Meeting: September 8, 2008, FDA sponsored a meeting to seek input on determining the data and test methods that are available, and to hear public comments and concerns regarding this class of compounds.

Chemistry Guidance for Food Contact Notifications December, 2007 Section II.A.5. Physical/Chemical Specifications: "...In cases where particle size is important to achieving the technical effect or may relate to toxicity, sponsors should describe particle size, size distribution, and morphology, as well as any size-dependent properties. Section II.C. Technical Effect: "...If technical effect is dependent on particle size, sponsors should present data that demonstrate the specific properties of the particles that make them useful for food-contact applications."

Nanotechnology and Guidance The potential for rapid development and introduction of FDA-regulated nanomaterials highlights the need for a transparent, consistent, and predictable regulatory pathway. The FDA Nanotechnology Task Force Report recommended development of appropriate guidance documents. In the interim, FDA is updating existing guidance for new submissions to include considerations relevant to nanoscale materials. Consult with us early and often